Beyond the hype: Understanding the limitations of sugammadex
Sugammadex represents a major advance in neuromuscular blockade reversal but remains an imperfect agent. Safe and effective use requires individualized dosing guided by quantitative neuromuscular monitoring and vigilance for adverse effects. Pharmacists are well positioned to lead education, dosing protocol development, and monitoring strategies that optimize patient safety while supporting adoption of quantitative neuromuscular monitoring.
Authors
- Sorin J. Brull (ORCID: https://orcid.org/0000-0003-2607-2590)
- Dustin D Linn (ORCID: https://orcid.org/0000-0002-7788-716X)
- J Ross Renew
Institutions
- University of Debrecen (HU)
- Jacksonville College (US)
- Parkview Health (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2026-03-21
- DOI
- https://doi.org/10.1093/ajhp/zxag094
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00